These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 24980966)

  • 41. Utilization of opportunistic cervical cancer screening in Nigeria.
    Habila MA; Sagay E; Obeng-Kusi M; Ali MJ; Magaji FA; Shambe IH; Daru PH; Jacobs ET; Madhivanan P; Sagay AS; Musa J
    Cancer Causes Control; 2024 Jan; 35(1):9-20. PubMed ID: 37530986
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Awareness and knowledge regarding of cervical cancer, Pap smear screening and human papillomavirus infection in Gabonese women.
    Assoumou SZ; Mabika BM; Mbiguino AN; Mouallif M; Khattabi A; Ennaji MM
    BMC Womens Health; 2015 Apr; 15():37. PubMed ID: 25924940
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cervical cancer awareness and screening in Botswana.
    Mingo AM; Panozzo CA; DiAngi YT; Smith JS; Steenhoff AP; Ramogola-Masire D; Brewer NT
    Int J Gynecol Cancer; 2012 May; 22(4):638-44. PubMed ID: 22367370
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Factors affecting Pap smear uptake in a maternity hospital: A descriptive cross-sectional study.
    Yeo C; Fang H; Thilagamangai ; Koh SSL; Shorey S
    J Adv Nurs; 2018 Nov; 74(11):2533-2543. PubMed ID: 29920737
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cervical cancer screening among HIV-infected women in a health department setting.
    Logan JL; Khambaty MQ; D'Souza KM; Menezes LJ
    AIDS Patient Care STDS; 2010 Aug; 24(8):471-5. PubMed ID: 20653483
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Factors influencing the prevalence of cervical cancer screening in Malaysia: a nationwide survey.
    Chan YM; Ismail MZH; Khaw WF
    BMC Womens Health; 2023 Jul; 23(1):389. PubMed ID: 37491253
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Knowledge, Attitudes and Practices of Sudanese Women Regarding the Pap Smear Test and Cervical Cancer.
    Almobarak AO; Elbadawi AA; Elmadhoun WM; Elhoweris MH; Ahmed MH
    Asian Pac J Cancer Prev; 2016; 17(2):625-30. PubMed ID: 26925654
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Improved awareness of Pap smear may not affect its use in Nigeria: a case study of female medical practitioners in Enugu, southeastern Nigeria.
    Dim CC; Ekwe E; Madubuko T; Dim NR; Ezegwui HU
    Trans R Soc Trop Med Hyg; 2009 Aug; 103(8):852-4. PubMed ID: 19394990
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Knowledge about cervical cancer, Pap test, and barriers to women's participation in screening in Belgrade, Serbia.
    Jovanovic V; Mitrovic Jovanovic A; Zivanovic A; Kocic S; Vasiljevic M; Krasic V
    Eur J Gynaecol Oncol; 2017; 38(1):69-75. PubMed ID: 29767868
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Sociodemographic factors of Pap smear screening in Taiwan.
    Wang PD; Lin RS
    Public Health; 1996 Mar; 110(2):123-7. PubMed ID: 8901257
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evaluation of the pap smear test status of Turkish women and related factors.
    Karabulutlu O
    Asian Pac J Cancer Prev; 2013; 14(2):981-6. PubMed ID: 23621272
    [TBL] [Abstract][Full Text] [Related]  

  • 52. An appraisal of the level of awareness and utilization of the Pap smear as a cervical cancer screening test among female health workers in a tertiary health institution.
    Gharoro EP; Ikeanyi EN
    Int J Gynecol Cancer; 2006; 16(3):1063-8. PubMed ID: 16803486
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cervical cancer screening among Lebanese women.
    Bou-Orm IR; Sakr RE; Adib SM
    Rev Epidemiol Sante Publique; 2018 Feb; 66(1):1-6. PubMed ID: 29249573
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Low uptake of Pap smear testing among medical clinic attendees in a tertiary care hospital in Sri Lanka.
    Shivanthan MC; Arunakiri K; Wickramasinghe SI; Sumanasekera RD; Jayasinghe S; Rajapakse S
    Int Health; 2014 Jun; 6(2):138-43. PubMed ID: 24737803
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pap smear screening at an urban aboriginal health service: report of a practice audit and an evaluation of recruitment strategies.
    Hunt JM; Gless GL; Straton JA
    Aust N Z J Public Health; 1998 Oct; 22(6):720-5. PubMed ID: 9848971
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Knowledge and practice of cervical cancer screening using Pap smear among women attending antenatal clinic at Aba, south-eastern Nigeria.
    Onwere S; Okoro O; Chigbu B; Onwere A
    Niger J Clin Pract; 2009 Sep; 12(3):341-2. PubMed ID: 19803042
    [No Abstract]   [Full Text] [Related]  

  • 57. Cervical Cancer Screening and Incidence by Age: Unmet Needs Near and After the Stopping Age for Screening.
    White MC; Shoemaker ML; Benard VB
    Am J Prev Med; 2017 Sep; 53(3):392-395. PubMed ID: 28473240
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Study protocol for the most effective recall method in a cervical cancer screening program in Klang, Malaysia.
    Abdul Rashid RM; Dahlui M
    Asian Pac J Cancer Prev; 2013; 14(10):5867-70. PubMed ID: 24289591
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Factors associated with lack of Pap smear screening in a group of postmenopausal Brazilian women].
    Brischiliari SC; Dell'Agnolo CM; Gil LM; Romeiro TC; Gravena AA; Carvalho MD; Pelloso SM
    Cad Saude Publica; 2012 Oct; 28(10):1976-84. PubMed ID: 23090176
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prevalence and risk factors of cervical cancer among women in an urban community of Kwara State, north central Nigeria.
    Durowade KA; Osagbemi GK; Salaudeen AG; Musa OI; Akande TM; Babatunde OA; Raji HO; Okesina BS; Fowowe AA; Ibrahim OO; Kolawole OM
    J Prev Med Hyg; 2012 Dec; 53(4):213-9. PubMed ID: 23469591
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.